迈威生物(Mabwell)自研抗ST2单克隆抗体9MW1911获新药临床试验(IND)批准,即将开展IIa期研究
(SeaPRwire) – […]
(SeaPRwire) – […]
(SeaPRwire) – […]
(SeaPRwire) – […]
(SeaPRwire) – […]
(SeaPRwire) – CHI […]
(SeaPRwire) – […]
(SeaPRwire) – […]
(SeaPRwire) – […]
(SeaPRwire) – […]
(SeaPRwire) – […]
(SeaPRwire) – […]